Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |